2-isopropyl-3-methylquinoxaline | 40790-43-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-isopropyl-3-methylquinoxaline
• 英文别名: 2-Isopropyl-3-methyl-chinoxalin；2-methyl-3-propan-2-ylquinoxaline
• CAS: 40790-43-0
• 化学式: C₁₂H₁₄N₂
• 分子量: 186.257
• InChiKey: LRDBSRNPJQJWMO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-isopropyl-3-methylquinoxaline 在 氢氧化钾 、 potassium permanganate 作用下， 以 水 为溶剂， 反应 1.0h， 生成 5-Isopropyl-6-methyl-pyrazine-2,3-dicarboxylic acid
  参考文献：
  名称：

  Heyns, Kurt; Behse, Ernst; Francke, Wittko, Chemische Berichte, 1981, vol. 114, # 1, p. 240 - 245

  摘要：

  DOI：
• 作为产物：
  描述：

  2-isopropyl-3-methyl-quinoxaline 1,4-dioxide 在 sodium dithionite 作用下， 以 甲醇 、 水 为溶剂， 反应 3.0h， 以94%的产率得到2-isopropyl-3-methylquinoxaline
  参考文献：
  名称：

  Heyns, Kurt; Behse, Ernst; Francke, Wittko, Chemische Berichte, 1981, vol. 114, # 1, p. 240 - 245

  摘要：

  DOI：

文献信息

• HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSTION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT
  申请人：KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY

  公开号：US20180105527A1

  公开（公告）日：2018-04-19

  The present invention relates to a heteroaryl derivative or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition for preventing or treating diseases associated with PI3 kinases, containing the same as an active ingredient. The heteroaryl derivative according to the present invention has an excellent effect of selectively inhibiting PI3 kinases, thereby being useful in preventing or treating PI3 kinase diseases such as: cancers, autoimmune diseases, and respiratory diseases.

  本发明涉及一种杂环芳基衍生物或其药用可接受盐，以及其制备方法和包含其作为活性成分的用于预防或治疗与PI3激酶相关疾病的药物组合物。根据本发明的杂环芳基衍生物具有优异的选择性抑制PI3激酶的效果，因此在预防或治疗癌症、自身免疫疾病和呼吸道疾病等PI3激酶疾病方面具有用处。
• [EN] SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS D'OXOISOINDOLINE SUBSTITUÉS POUR LE TRAITEMENT DU CANCER
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2021194914A1

  公开（公告）日：2021-09-30

  Disclosed are compounds of Formula (I) or a salt thereof, wherein Ring A is a carbon-linked ring; and Ring A, R1, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

  揭示了化合物的结构式（I）或其盐，其中环A是一个碳链环；环A，R1和n在此处有定义。还揭示了使用这些化合物抑制Helios蛋白的方法，以及包含这些化合物的药物组合物。这些化合物在治疗病毒感染和增生性疾病（如癌症）方面具有用途。
• Asymmetric Transfer Hydrogenations of 2,3-Disubstituted Quinoxalines with Ammonia Borane
  作者：Songlei Li、Wei Meng、Haifeng Du

  DOI：10.1021/acs.orglett.7b00935

  日期：2017.5.19

  An asymmetric transfer hydrogenation of 2,3-disubstituted quinoxalines using a chiral frustrated Lewis pair of Piers’ borane and (R)-tert-butylsulfinamide as the catalyst with ammonia borane as the hydrogen source has been successfully realized. For 2-alkyl-3-arylquinoxaline substrates, cis-tetrahydroquinoxalines were obtained as the predominant products in high yields with 77–86% ee. In contrast,

  成功地实现了以手性失意的Piers's硼烷和（R）-叔丁基亚磺酰胺为手性受阻Lewis对，以氨硼烷为氢源的2,3-二取代喹喔啉的不对称转移氢化。对于2-烷基-3-芳基喹喔啉底物，以高收率（77-86％ee）获得了主要产物顺式-四氢喹喔啉。相反，反式异构体通常作为主要产物用于2，3-二烷基喹喔啉与ee高达99％以上的反应。
• Continuous-flow synthesis of alkyl zinc sulfinates for the direct photofunctionalization of heterocycles
  作者：José Luis Nova-Fernández、Montaña J. García、Leonardo Mollari、Gustavo Pascual-Coca、Silvia Cabrera、José Alemán

  DOI：10.1039/d2cc01065h

  日期：——

  A sustainable strategy for the alkylation of heterocycles is presented. The protocol relies on the in situ generation and further in-line use of alkyl zinc sulfinates through a continuous-flow system. The environmentally friendly character of the protocol is assured by the use of a green solvent mixture, the presence of a metal free oxidant and low waste generation.

  提出了一种用于杂环烷基化的可持续策略。该协议依赖于原位生成和通过连续流动系统进一步在线使用烷基亚磺酸锌。该协议的环保特性是通过使用绿色溶剂混合物、无金属氧化剂的存在和低废物产生来保证的。
• Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
  申请人：Bergeron Philippe

  公开号：US20070015773A1

  公开（公告）日：2007-01-18

  Compounds, compositions and methods that are useful in the treatment of inflammatory and immune conditions and diseases are provided herein. In particular, the invention provides aryl nitrile compounds which modulate the expression and/or function of a chemokine receptor. The subject methods are useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis, type I diabetes, asthma, psoriasis and inflammatory bowel disease.

  本文提供了在治疗炎症和免疫相关疾病中有用的化合物、组合物和方法。具体来说，本发明提供了可以调节趋化因子受体的表达和/或功能的芳基腈化合物。这些方法适用于治疗炎症和免疫调节性疾病，例如多发性硬化症、类风湿性关节炎、1型糖尿病、哮喘、牛皮癣和炎症性肠病。